Colocalization of Glial Fibrillary Acidic Protein, Metallothionein, and MHC II in Human, Rat, NOD/SCID, and Nude Mouse Skin Keratinocytes and Fibroblasts  by Danielyan, Lusine et al.
Colocalization of Glial Fibrillary Acidic Protein,
Metallothionein, and MHC II in Human, Rat,
NOD/SCID, and Nude Mouse Skin Keratinocytes
and Fibroblasts
Lusine Danielyan1, Genrich Tolstonog2, Peter Traub2, Juergen Salvetter3, Christoph H. Gleiter1,
Dieter Reisig3, Rolf Gebhardt4 and Gayane H. Buniatian1,4
The expression of glial fibrillary acidic protein (GFAP) by perivascular cells of many mammalian organs suggests
an as yet unknown function of this intermediate filament protein in the maintenance of homeostasis and
vascular permeability at the blood–tissue interface. Although a similar situation may exist at the air–tissue
interface, the cellular distribution of GFAP in skin tissue has never been demonstrated. To approach this issue,
we have employed immunofluorescence and Western blotting techniques to detect GFAP in skin sections of
young and adult humans, normal rodents, and two types of mutant mice, as well as in rat lung sections, and in
cultured human keratinocytes and fibroblasts. Colocalization with antigens known to be associated with GFAP
in other tissues was also tested. Epidermal and hair follicle keratinocytes and dermal fibroblasts showed distinct
staining for GFAP as well as colocalization with alpha-actin, metallothionein, and antigens of the class-II major
histocompatibility complex (MHC II). GFAP was also identified in rat alveolar fibroblasts which, in common with
keratinocytes, form part of the air–tissue interface. GFAP was upregulated together with MHC II in nude mice
but was barely detectable in the skin of non-obese diabetic severe combined immunodeficiency mice,
suggesting a possible involvement in antigen-presenting functions. The intriguing distribution of a common set
of antigens both in certain cells of the integumentary system and at the blood–tissue interfaces of internal
organs suggests the involvement of these proteins in universal mechanisms controlling tissue homeostasis and
protection.
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INTRODUCTION
Glial fibrillary acidic protein (GFAP) is a highly conserved
intermediate filament (IF) protein originally considered as a
marker protein for astrocytes (Brenner, 1994). Meanwhile,
GFAP mRNA protein has also been detected in many non-
neural cells of the same anatomy as astrocytes. An increasing
body of evidence now demonstrates the accumulation of
GFAP in lens epithelial cells, Leydig cells of testis, hepatic
stellate cells (HSCs), podocytes, mesangial cells, pancreatic
stellate cells, fibroblasts, and chondrocytes of elastic cartilage
in epiglottis (for review, see Apte et al., 1998; Buniatian,
2001; Hainfellner et al., 2001). The common antigenic
composition of GFAP-producing cells (GFAP-PCs) was
interpreted as a hint on a possible similar developmental
origin of these cells (Schulze et al., 1987; Holash et al., 1993;
Cassiman et al., 1999). In these cells, GFAP has been found to
be associated with other IF proteins such as vimentin,
desmin, nestin, and smooth muscle alpha-actin (SMAA;
Lecain et al., 1991; Bunn et al., 1999; Buniatian et al.,
1999a, b; Steinert et al., 1999; Lonigro et al., 2001; Schwab
et al., 2001; Peterson et al., 2004; Mani et al., 2005). Even
more surprising, in peripheral organs, GFAP-PCs, that is,
HSC, kidney glomeruli mesangial cells, and podocytes were
found to express certain proteins usually associated with
brain-specific protecting functions of astrocytes such as
metallothionein (MT) and major histocompatability complex
II (MHC II) (Buniatian et al., 2001; Lu et al., 2001; Riccalton-
Banks et al., 2003). These observations led to the hypothesis
that GFAP-PCs play an indispensable, but still largely
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unknown role at the blood–tissue interface of neural and non-
neural organs with respect to tissue protection and main-
tenance of homeostasis (Buniatian, 2001; Buniatian et al.,
2002). The apparent universality of this concept prompted us
to investigate whether it might apply also to tissues of the
integumentary system, that is, to cells located at the air–body
interface. Therefore, we investigated the localization of GFAP
in skin samples of different species including normal and
mutant strains of mice. The latter, nude mice and non-obese
diabetic (NOD)/severe combined immunodeficiency (SCID)
mice, provided novel insight into possible functional aspects
of the colocalization with MHC II and other antigens studied.
RESULTS
Human skin sections
In situ staining of human epidermal keratinocytes. Labelling
of young human skin slices with monoclonal antibodies
(mAb) (Figure 1a) or polyclonal antibodies (pAb) directed
against bovine GFAP (Figure 1b) showed the presence of this
astrocyte marker protein in keratinocytes through all layers of
the epidermis: stratum basalis (white arrows throughout
Figure 1), stratum spinosum, stratum granulosum, and stratum
corneum (blue arrows throughout Figure 1). The non-
filamentous GFAP staining pattern perfectly delineated the
crypt-like structure of the epidermis and separated it from
dermis. The strongest expression of GFAP was observed in
keratinocytes in stratum corneum and in stratum basalis
(Figure 1a and b). Localization of GFAP predominated in
peripheral parts but also occurred in nuclear region of the
cells (Figure 1b, c, and f).
The micrographs of mono- (Figure 1d) and double-
immunofluorescence (Figure 1c) studies illustrate that desmin
(red), another type III IF protein, was weakly produced in
GFAP-expressing (green) keratinocytes. Vimentin (red), the
third type III IF protein investigated in this study, was also
weakly formed in epidermal keratinocytes (blue arrow in
Figure 1e). Although SMAA was generally weak in epidermal
keratinocytes, some cells showed a prominent nuclear
staining (red, Figure 1g) that occasionally appeared yellow
in the micrographs (Figure 1f), indicating colocalization of
SMAA (red), and GFAP (green) in the nuclear region of some
keratinocytes. GFAP was expressed in sweat glands, vessels,
and hair follicles (yellow arrowheads, white arrowheads, red
arrowheads in Figure 1h, respectively).
MT was strongly expressed in epidermal keratinocytes
(red, Figure 1i). In the cornified layer of epidermis (blue arrow
in Figure 1i), the cells produced high amounts of both, GFAP
(green) and MT (red), resulting in yellow structures in merged
micrographs (Figure 1i). Although GFAP and MT seemed
equally coexpressed throughout the epidermis, in some
regions, especially in the papilla (red arrow in Figure 1i),
keratinocytes expressed MT (red) more strongly than GFAP
(green).
In adult human skin, the pattern of GFAP (green)
localization was not changed (Figure 1j and k). It was well
expressed in skin epidermis and parts of dermis (Figure 1k),
and was colocalized primarily with MHC-II (red in Figure 1j)
in epidermal keratinocytes.
In situ staining of human dermal fibroblasts. Both, mAb
GFAP (Figure 1a) and pAb GFAP (green in Figure 1b, c, e, f, h,
and i), labelled some fibroblasts in the lower parts of the
dermis (magenta arrows throughout Figure 1). In the upper
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Figure 1. Astrocyte-associated antigens in (a–i) frozen young (10 years) and
(j, k) adult human skin sections. (a) Expression of GFAP detected using mouse
mAb GFAP. (b) Expression of GFAP detected using rabbit pAb GFAP.
(c) Double staining for GFAP (green) and desmin (red). (d) Staining for desmin
alone. (e) Double staining for GFAP (green) and vimentin (red). (f) Double
staining for GFAP (green) and SMAA (red). (g) Staining for SMAA alone.
(h) Double staining for GFAP (green) and SMAA (red). (i) Double staining for
GFAP (green) and MT (red). (j) Double staining for GFAP (green) and MHC II
(red). (k) Staining for GFAP (green). Blue arrows point to stratum corneum,
white arrows to stratum basalis, yellow arrows to fibroblasts adjacent
to stratum basalis, red arrows to papilla structures, and magenta arrows
to fibroblasts in the lower layers of dermis. Yellow arrowheads to sweat
glands, white arrowheads to vessels, and red arrowheads to hair follicles.
Cy3-conjugated anti-mouse IgG from goat was used for the detection of
mouse mAb GFAP, mAb desmin, mAb vimentin, mAb SMAA, and mAb
MT-labelling sites. Skin structures labelled with rabbit pAb GFAP were
detected using FITC-conjugated anti-rabbit IgG from goat. The preservation
of skin structures and cells which could not be detected by distinct
antibodies was ascertained by counterstaining of cell nuclei by DAPI (blue).
Bar: in (a, e, f, h, i)¼ 10mm; in (b–d, g, j, k)¼ 20 mm.
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part of the dermis adjacent to the stratum basalis (yellow
arrows throughout Figure 1), fibroblasts were barely detect-
able when labelled with antibodies against GFAP (green in
Figure 1b, c, e, and f). Only in very few regions adjacent to
the stratum basalis, fibroblastic cells labelled with pAb GFAP
(yellow arrow in Figure 1i) could be observed. In contrast,
mAb against vimentin (red) intensely labelled the fibroblasts
adjacent to the stratum basalis of the epidermis (yellow arrow
in Figure 1e).
In the lower dermis, most fibroblasts (magenta arrows in
Figure 1) appeared to contain solely GFAP when simulta-
neously labelled with anti-GFAP (green) and anti-vimentin or
anti-SMAA antibodies (red in Figure 1e and h, respectively).
Only occasionally, GFAP was colocalized with vimentin
(Figure 1e) or with SMAA (Figure 1f and h). However, GFAP
and SMAA were colocalized in myofibroblastic cells forming
the vascular walls of the capillaries and middle-sized vessels
(white arrowheads in Figure 1h). GFAP-PCs could be
observed also in the inner part of sweat glands (yellow
arrowheads in Figure 1h) surrounded by a rim of contractile
cells detected by SMAA staining (red). Furthermore, GFAP
was expressed in keratinocytes surrounding the hair follicles
(red arrows in Figure 1g). The intensity of MT staining (red in
Figure 1i) in fibroblasts was weaker than that of GFAP (green
in Figure 1i).
Cultured human skin cells
The presence of GFAP in human skin keratinocytes and
fibroblasts was confirmed by immunocytochemical studies
performed on cultured cells (Figure 2). The merged micro-
graphs (Figure 2a) of double stainings for GFAP (green, Figure
2b) and MT (red, Figure 2c) of 14-day-old cultured human
keratinocytes showed strong expression of MT in young small
cobblestone-like cells, whereas GFAP was more intensely
stained in large, flattened keratinocytes. Some cells produced
equal amounts of GFAP and MT, as evidenced by bright,
yellow staining in merged images, but there were also cells in
which GFAP (green) prevailed over MT (red in Figure 2a). The
heterogeneity in the intensity of staining for both proteins in
neighboring cells was similar to that of seen by in situ staining
(cf. Figure 2a with Figure 1i).
Nearly, equal reaction of GFAP (Figure 2e) and desmin
(Figure 2f) in human fibroblasts from young cultures was
evidenced by bright yellow staining in merged micrograph
(Figure 2d) of these small cells. After 3 days in culture,
fibroblasts were activated and rapidly proliferated (cf. Figure
2d and g). The differentiation of fibroblasts was accompanied
by retraction of GFAP towards the perinuclear region and
downregulation in peripheral parts of the cells (Figure 2h),
increased expression of desmin (Figure 2i), and strong
upregulation of SMAA (not shown).
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Figure 2. Differentiation of human keratinocytes and fibroblasts in culture. (a–c) Double labelling of 7-day-old keratinocytes with pAb GFAP and mAb
MT: (a) merge of GFAP and MT staining; (b) staining for GFAP; and (c) staining for MT. (d–f) Double labelling of 2-day-old fibroblasts with pAb GFAP and
mAb desmin: (d) merge of GFAP and desmin staining; (e) staining for GFAP; and (f) staining for desmin. (g–i) Double labelling of 7-day-old fibroblasts with
pAb GFAP and mAb MT: (g) merge of GFAP and desmin staining; (h) staining for GFAP; and (i) staining for desmin. The secondary antibody used in (b, e, h)
was rabbit antiserum FITC-conjugated anti-rabbit IgG from goat, whereas in (c, f, i) was Cy3-conjugated anti-mouse IgG from goat. Bar¼ 20 mm.
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Rat skin sections
Epidermal keratinocytes from newborn rat skin (blue arrows
throughout Figure 3) accumulated large amounts of GFAP
(Figure 3a) and MHC II (Figure 3d), while weakly expressing
SMAA (Figure 3b) and vimentin (not shown). MT was
produced mainly by keratinocytes located in the inner layer
of the epidermis, that is, stratum basalis (not shown). GFAP-
expressing keratinocytes also delineated the outer sheet of
hair follicles (magenta arrows in Figure 3c, e, and f).
Concerning dermal fibroblasts, some of them solely ex-
pressed GFAP (yellow arrows pointing to green stained cells
in Figure 3c, e, and f), vimentin (yellow arrows pointing to
red stained cells in Figure 3f), or desmin (yellow arrows
pointing to red stained cells in Figure 3e), whereas others
coexpressed GFAP and vimentin, or desmin (different
nuances of staining of the cells labelled with yellow arrows
in the merged Figure 3c, e, and f). Inside hair follicles, GFAP,
SMAA, MHC II were strongly expressed in the cuticle (Cu)
and the medulla (M) of the hair channel (red arrows labelled
with M throughout Figure 3). In the follicle cortex (white
arrows throughout Figure 3), a population of cells surround-
ing the hair channel could be distinguished by 40,6
diamidino-2-phenylindole (DAPI) staining (blue in Figure 3f)
that did not stain for GFAP. In some follicles, however, the
cortical cells weakly expressed GFAP (green in Figure 3a and
e), and MHC II (red, Figure 3d).
Mouse skin sections
GFAP was strongly expressed in the epidermis and dermis of
CD1 BalbC (Figure 4b) and C57BL/6 mice (Figure 4e) similar
to human and rat skin. However, both CD1 BalbC (Figure 4c)
and C57BL/6 (Figure 4f) mouse strains overexpressed MHC II
in dermis relative to the epidermis contrasting with the
situation in humans and rats. In merged pictures (Figure 4a
and d), colocalization of both antigens was evident, although
the extent varied considerable ranging from slight costaining
to bright yellow fields of cells particularly in dermis of CD1
BalbC mice (Figure 4a).
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Figure 3. Astrocyte-associated antigens in frozen rat skin sections.
(a) Labelling with pAb GFAP. (b) Labelling with mAb SMAA (red). (c) Double
labelling with pAb GFAP (green) and mAb SMAA (red). (d) Labelling with
mAb MHC II. (e) Double labelling with pAb GFAP (green) and mAb desmin
(red). (f) Double labelling with pAb GFAP (green) and mAb vimentin. Skin
structures labelled with anti-GFAP were detected using FITC-conjugated anti-
rabbit IgG from goat, whereas Cy3-conjugated anti-mouse IgG from goat was
used for detection of mAb desmin, mAb vimentin, mAb SMAA, and mAb
MHC II. Blue arrows point to epidermis; yellow arrows to fibroblasts (F); white
arrows to follicle cortex (Co); red arrows to cuticle (Cu); and magenta arrows
to outer sheet of the hair follicles. Bar: in (a–d, f)¼ 10mm; in (e)¼ 20 mm.
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Figure 4. Colocalization of GFAP and MHC II in normal and mutant murine
skin. (a–c) Double staining of CD1 Balb C mouse skin sections for GFAP and
MHC. (a) Merged micrograph of GFAP and MHC immune reaction;
(b) staining for GFAP; and (c) staining for MHC II. (d–f) Double staining of
C75BL/6 mouse skin sections for GFAP and MHC II. (d) Merged micrograph of
GFAP and MHC immune reaction; (e) staining for GFAP; and (f) staining
for MHC II. (g–i) Double staining of CD1-Foxn1 nu nude mouse skin sections
for GFAP and MHC. (g) Merged micrograph of GFAP and MHC immune
reaction; (h) staining for GFAP; and (i) staining for MHC II. (j–l) Double
staining of NOD-SCID mouse skin sections for GFAP and MHC. (j) Merged
micrograph, staining for GFAP and MHC immune reaction; (k) staining for
GFAP; and (l) staining for MHC II. Skin structures labelled with anti-GFAP
were detected using FITC-conjugated anti-rabbit IgG from goat, whereas
Cy3-conjugated anti-mouse IgG from goat was used for detection of mAb
MHC II. Because MHC II was very strongly expressed in (a, c) CD1 BalbC,
(d, f) C57BL/6, and in (g, i) nude mice, the images illustrating immunoreaction
of MHC II had to be taken at 10-fold faster exposure (less sensitivity) than
those of GFAP, whereas in (j, l) NOD/SCID mice exposure times were
equal. Blue arrows point to epidermis; yellow arrows to dermal fibroblasts;
and white arrows to follicles. Bar¼10 mm.
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To test the hypothesis that GFAP might be associated with
protection and antigen-presenting functions involving MHC
II, we used two types of mutant mice, nude mice and NOD/
SCID mice, which are a priori known to over- and under-
express MHC II, respectively. In nude mice (Figure 4g–i), both
MHC II (red) and GFAP (green) were upregulated. Careful
inspection of the results of double-staining experiments
showed that nearly all the cells stained for MHC also
costained for GFAP (Figure 4g). This was evident by multiple
yellow stained dermal cells in the merged micrograph in
Figure 4g. In contrast to control BalbC and C57BL/6 mice skin
in which cortical cells in the hair follicles were visualized
only by DAPI and barely detectable staining for MHC II and
GFAP, in nude mice the follicles were strongly enlarged and
contained large amounts of GFAP (green, cf. white arrows in
Figure 4b, e, and h). In the opening of these follicles, also few
cells expressing MHC could be distinguished (Figure 4i).
In NOD/SCID mouse skin sections (Figure 4j–l), both
GFAP (green, Figure 4k) and MHC II (red, Figure 4l) were
strongly downregulated, both in dermis and epidermis. The
skin of these mutant mice contained follicles which could be
visualized only by nuclear staining with DAPI (white arrows
in Figure 4j–l).
The authenticity of GFAP localization in skin
Different approaches were used to confirm the specificity of
GFAP staining in different skin samples:
1. Omission of primary antibodies: In control immuno-
labelling studies performed on human (Figure 5e), rat, and
mouse skin sections (not shown), the primary antibodies were
omitted. The sections were treated only with a mixture of
rabbit antiserum and FITC-conjugated anti-rabbit IgG from
goat and Cy3-conjugated anti-mouse IgG from goat and
mounted in mounting medium containing DAPI. This resulted
in disappearance of the cellular contours – the cells could be
identified only by bright DAPI-stained chromatin (Figure 5e).
2. Confocal laser scanning (CLS) microscopy: In Figure 5,
representative serial optical sections are shown obtained by
CLS microscopy of newborn rat skin slices (Figure 5a),
cultured human skin fibroblasts (Figure 5c), as well as
newborn rat lung slices (Figure 5d) immunolabelled with
pAb GFAP. CLS immunofluorescence microscopy confirmed
the results obtained by using widefield microscopy: GFAP is
expressed in epidermal keratinocytes (blue arrows), in
keratinocytes forming the outer sheet of hair follicles, in the
hair cuticle (Cu), in the cortical area (Co) of the follicle
(Figure 5a), and in dermal fibroblasts (Figure 5c). Moreover,
CLS microscopy evidenced the presence of GFAP in the
cytoplasm and nucleus of cultured skin fibroblasts (Figure
5c). To demonstrate that GFAP is also present in other cells
contacting air, we performed a single experiment on
newborn rat lung. CLS microscopy revealed the presence of
GFAP in fibroblasts surrounding the alveoli (Figure 5d).
3. Western blot assay: The presence of GFAP in skin was
confirmed also by Western blot assay (Figure 4f and g),
demonstrating the specificity of mAb against GFAP. Immuno-
blot analysis was performed using protein extracts prepared
from newborn rat skin (Figure 4f). The T6 cell line, an
activated HSC line (Kim et al., 1998), as well as extracts of
14-day-old astroglial cells were used for comparison (Figure
4g), that is, cells a priori known to contain GFAP. The immuno-
reaction with mAb GFAP uncovered two major bands with
apparent molecular masses ofB55 andB52 kDa in newborn
rat skin. The thickness and intensity of staining of these bands
diminished with decreasing protein concentration (Figure 4f).
Similar patterns of immunoreaction were obtained in blots of
the T6 cell line (Figure 4g, lane 1) and of astroglial cells
(Figure 4g, lane 2). Weak immunoprecipitate in the samples
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Figure 5. The authenticity of GFAP expression in skin. (a–d) CLS microscopy
of skin preparations stained for GFAP. (a) Labelling of newborn rat skin
sections with pAb GFAP. (b) Phase contrast micrograph of the field shown in
(a). (c) Cultured human fibroblasts stained for GFAP. (d) Labelling of newborn
rat lung section with pAb GFAP. GFAP was detected using rabbit antiserum
and FITC-conjugated anti-rabbit IgG from goat. Blue arrows point to
epidermis; yellow arrows to fibroblasts (f); white arrows to follicle cortex (Co);
red arrows to cuticle (Cu); and magenta arrows to outer sheet of the hair
follicles. (e) Control widefield immunofluorescence assay: human skin section
treated with mixture of FITC-conjugated anti-rabbit IgG from goat and Cy3-
conjugated anti-mouse IgG from goat. Bar: in (a, b)¼ 10 mm; in (c–e,)¼ 20 mm.
(f, g) Immunoblot analysis of GFAP. (f) Immunoblot analysis of GFAP in
homogenates of newborn rat skin (lane 1, 34.5 mg; lane 2, 3.0 mg; and
lane 3, 1.5 mg); (g) immunoblot analysis of GFAP in homogenates of T6
cells (lane 1, 12.5 mg) and newborn rat astroglial culture (lane 2, 21.5 mg).
In all tested tissues, mAb GFAP labelled two major protein bands with
apparent molecular masses of B55 and B52 kDa.
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of the T6 cell line (Figure 4g, lane 1) is in accordance with
downregulation of GFAP during HSC activation (Buniatian
et al., 1996a; Niki et al., 1996). Also, the abundance of GFAP
in astroglial cells from confluent astroglial culture (Figure 4g,
lane 2) is in accordance with the well-established capacity of
differentiated astrocytes to produce large amounts of GFAP
(Wagner et al., 1993).
DISCUSSION
We describe here the presence of high levels of GFAP in the
epidermis and dermis of both humans and rodents. This
expression of GFAP at the air–tissue interface established by
cells of the integumentary system parallels that previously
described in both neural and non-neural cells adjacent to the
blood–tissue interface.
The presence of GFAP in keratinocytes and skin fibroblasts
was confirmed by both widefield and CLS microscopy using
mAbs and pAbs, and by Western blot analysis. Our detection
of GFAP in the nucleus of activated cultured fibroblasts is
consistent with in vitro studies demonstrating the capacity of
type III IF proteins to interact with DNA (Traub, 1995;
Tolstonog et al., 2000). As reported previously, selection of
appropriate antibodies is essential for detecting GFAP in non-
neural tissues (Hainfellner et al., 2001). The consistent
detection of a 55-kDa protein on Western blots strongly
suggests that the mAb GFAP used here specifically recognizes
GFAP. The additional 52-kDa band detected in the Western
blots is likely to be a product of alternative splicing of rat
GFAP mRNA as has been previously observed in rat brain,
where four alternatively spliced transcripts have been
detected (Condorelli et al., 1999). Further evidence for the
specificity of GFAP detection is provided by (a) heterogeneity
in the pattern of GFAP staining between neighboring cells
and regions of epidermis and dermis, (b) low overall staining
intensity (with the exception of few areas in most of which
GFAP was colocalized with MHC II) in skin sections of NOD/
SCID mice which produce only small amounts of GFAP, and
(c) absence of any staining in control sections treated with
secondary antibodies only.
Our analyses have revealed a striking similarity between
skin cells expressing GFAP and other GFAP-PCs at blood–-
tissue interfaces of internal organs with respect to the
colocalization of certain antigens involved in protective
functions, exemplified here by MHC II and MT. The skin
raises an immune barrier to infection and possesses
considerable innate immune capacity (Oren et al., 2003;
Dupasquier et al., 2004). A number of studies have shown
that keratinocytes are capable of initiating local immune
responses by production of MHC II (Gaspari, 1997; Gaspari
and Katz, 1988). Our results confirm these observations,
but emphasize species-specific differences in this pattern.
Whereas expression of MHC II in human and rat skin is
higher in epidermis than in dermal fibroblasts, in both mouse
strains it is higher in the dermis than in the epidermis. This
may be explained by the recent finding of Dupasquier
et al. (2004) that in normal murine species, macrophages and
other CD45þ cells constitute a major subpopulation (about
70%) of cells in the dermis. The slight heterogeneity in the
MHC II/GFAP ratio between different murine skin cells is
consistent with previous observations of heterogeneity in the
antigenic composition of antigen-presenting cells in murine
dermis reported by Duraiswamy et al. (1994).
Most strikingly, our results point to a remarkable associa-
tion between the antigen-presenting function of skin keratino-
cytes and fibroblasts and the expression of GFAP. This is most
apparent in mutant mice of the nude phenotype (CD1 nu/
nu), in which MHC II and GFAP are strongly upregulated in
all dermal cells, although slight differences between different
cell types may exist. GFAP upregulation is especially
pronounced in the enlarged hair follicles characteristic for
the nude phenotype and may be owing to a compensatory
response to the downregulation of certain cytokeratins
resulting from loss of the foxn1 transcription factor (for
review, see Mecklenburg et al., 2005). Whether the
upregulation of MHC II is a direct or indirect consequence
of the loss of foxn1 remains to be established. Interestingly,
the hypertrophy of follicles in nude mice is a feature also
observed during hair loss in humans. There, hypertrophy of
follicles is known to be associated with a perifollicular
lymphocytic infiltrate made up primarily of CD4þ cells,
together with a CD8þ intrafollicular infiltrate and immune
activation indicated by expression of HLA-DR; HLA-A, -B,
and -C on the follicular epithelium (Gilhar and Kalish, 2006).
Conversely, in NOD/SCID mice, both GFAP and MHC II
were barely detectable in the skin, either in the dermis or the
epidermis. The NOD/SCID mice used here have a complex
genotype, as they express only one MHC class II molecule:
the I-Ag7 allele (Reizis et al., 1997) are double homozygous
for the SCID mutation (Ueda et al., 2000) and carry the IL-2
receptor g allelic mutation (gc
null) (Mamoru et al., 2002). For
this reason, there is no immediate indication of how the
parallel downregulation of GFAP and MHC II might be
mediated. The reduction in macrophage function apparent in
these mice probably contributes to lowering MHC II staining
in the dermis, but our results suggest that there may be an
additional coordinated response in GFAP-PCs. The possibility
is that this is a consequence of the IL-2 receptor g null
mutation that needs to be addressed in further studies.
A comparison of the properties of GFAP-PCs in the
integumentary system and in inner organs lends further
support to a functional association between GFAP and MHC
II. In skin, the absence of MHC II has been noted in diseases
that affect pigmentation (Marks et al., 2003). In this respect, it
is interesting that both MHC II and GFAP are expressed at
very low levels in melanoma sections, that is, under
conditions requiring avoidance of immune surveillance
(article in preparation). In inner organs, coexpression of
GFAP and MHC II is apparent in healthy spleen antigen-
presenting cells; non-differentiated HSCs (Buniatian, 2001,
2003b, unpublished results; Riccalton-Banks et al., 2003;
Vinas et al., 2003); healthy kidney glomerular mesangial
cells, and podocytes (Pfaff et al., 1999) – all cells located
adjacent to fenestrated capillaries. Furthermore, the parallel
upregulation of GFAP and MHC II has been described in
astrocytes during pathologic situations involving disturbance
of the blood–brain barrier (Ransohoff and Estes, 1991;
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Zeinstra et al., 2000), which are further characterized by the
acquisition of antigen-presenting capacity by microglia and
invasion of T lymphocytes specific for neural antigens within
the central nervous system (Lassmann et al., 1994; Neumann,
2001). Thus, GFAP might be an indicator of specific local
antigen-presenting functions in the skin and other organs.
Skin cells show a general colocalization of MT with GFAP,
although the MT/GFAP ratio may vary and appears to be
highest in the basal layer and in distinct structures such as the
papilla. The mAb against MT used in this study specifically
reacts with Cd/Zn-MT-I – a molecular species of MT which is
not found in quiescent HSC, but is expressed upon activation
(Buniatian et al., 2001; Lu et al., 2001). The same is true for
functionally active astrocytes and for activated podocytes and
mesangial cells (for review, see Chin and Templeton, 1993;
Buniatian et al., 2001, 2002). Thus, colocalization of GFAP
and MT in certain skin cells at the air–tissue interface is
indicative of an activated phenotype. In this respect, it is
noteworthy that the MT gene is upregulated in skin following
topical application of zinc and copper, and in wound
margins, particularly in regions of high mitotic activity (for
review, see Lansdown, 2002).
In conclusion, the skin shows a high proportion of GFAP-
PC, supporting the view that cells of this phenotype play an
important role in forming a permselective barrier not only at
blood–tissue interfaces in internal organs (Buniatian, 2001,
2003a, b), but also at the air–body interface in the integu-
mentary system. The coordinated expression of specific
molecules involved in protection and proliferation (MT,
MHC II) further emphasizes the important role of the skin in
the defense of the whole organism against environmental
insults.
MATERIALS AND METHODS
Antibodies
mAb against GFAP, clone GF 12.24 (dilution 1:10, Progen
Biotechnik GmbH, Heidelberg, Germany); pAb against bovine
GFAP (dilution 1:250 Dako, Glostrup, Denmark); Mouse mAb
against porcine vimentin, clone 9 (dilution 1:40 Sigma, Deisenho-
fen, Germany); Mouse mAb against porcine desmin, clone DE-U10
(dilution 1:33, Amersham-Buchler Braunschweig, Germany); Mouse
mAb against SMAA, derived from clone ASM-1 (dilution 1:100
Progen, Heidelberg, Germany); Mouse mAb against MHC II (dilution
1:100, Harlan Sera-Lab Limited (Loughborough, UK); Mouse mAb
against Cd/Zn-MT (1.7 mg/ml, dilution 1:100) was generous gift of
Dr U. Weser, Institute of Biochemistry of University of Tu¨bingen,
Germany (Nagel et al., 1990; Buniatian et al., 2001); FITC-labelled
goat anti-rabbit IgG (dilution 1:100), Cy3-conjugated goat anti-
mouse IgG (dilution 1:800) and Horseradish Peroxidase HRP-goat anti-
mouse IgG conjugate (dilution 1:1000 Dianova GmbH, Hamburg,
Germany).
Animals
All rats and mice were maintained at the central animal facility
according to Institutional Guidelines for Ethical Care of Animals.
C57BL/6 and CD1 BalbC mice were bred at the same animal facility
and used as skin donors after 1–2 weeks of age. NOD/SCID/gc
null and
CD1-Foxn1 nu mice were originally bought from Charles River
(Sulzfeld, Germany) as were newborn Sprague–Dawley rats
(250–300 g).
Human skin
The experiments were performed using operative material obtained
from the Childrens Hospital or the dermatological department of the
University of Leipzig. Samples of human foreskin and adult skin from
healthy skin regions adjacent to operated areas, were obtained with
consent from patients in accordance with the Declaration of Helsinki
Principles and under the license of the Ethic Commission of the
Leipzig University. Cell cultures were established from postoperative
tissues taken from healthy areas of foreskins. The foreskins from 2- to
8-year-old children were placed in sterile phosphate-buffered saline
(PBS) immediately after operation stored at 41C until use.
Rodent skin
Samples of rat skin were prepared from the scalp of newborn rats
after extirpation of the brain which was used for the preparation of
astroglial primary cultures. Likewise, samples from mouse skin were
extirpated from the same area of mice used for the preparation of
hepatocytes. Skin material was freed from fat and frozen immedi-
ately at 801C.
Cell culture
Keratinocytes. Primary normal human epidermal keratinocytes
were isolated from the foreskins of 2- to 8-year-old children as
described previously (Zellmer and Reissig, 2001), seeded in Petri
dishes containing coverslips. The cells were grown in serum-free
keratinocyte growth medium (Clonetics, San Diego, CA) containing
0.15 mM CaCl2, 0.1 mg/ml human epidermal growth factor (Clo-
netics), 0.5 mg/ml hydrocortisone, 5 mg/ml insulin, 30 mg/ml bovine
pituitary extract, 50 mg/ml gentamycin, and 50 mg/ml amphotericin.
Cultures were terminated at day 7 by brief washing in PBS, followed
by fixation in ice-cold methanol at 201C for 10 minutes.
Fibroblasts. Monolayers of normal human dermal fibroblasts from
the foreskins of 2- to 8-year-old children were obtained from
explants culture of de-epidermized skin and cultured in DMEM
containing 10% heat-inactivated fetal calf serum (Gibco, Grand
Island, NY), 50 mg/ml L-ascorbic acid, 100 U/ml penicillin, and
100mg/ml streptomycin sulfate, as described previously (Bayreuther
et al., 1992). The fibroblast cultures were kept in an incubator with
5% CO2 in air (95% humidity) at 371C. Cultures were terminated at
day 1 and 3 in culture as described above.
T6 cells. The GFAP-containing T6 cells, an activated HSC cell line
(Kim et al., 1998) was a generous gift of Dr Scott Friedman (Division
of Liver Diseases, Mount Sinai School of Medicine, New York). T6
cells from 5 to 10 passages were cultured in DMEM containing 10%
fetal calf serum, 20 U/ml penicillin 20mg/ml streptomycin sulfate.
Astrocytes. Astroglia-rich primary cultures were prepared from
brains of newborn rats as described elsewhere (Hamprecht and
Lo¨ffler, 1985).
Immunohistochemistry and immunocytochemistry
The foreskins from 2- to 8-year-old children, adult human skin, rat,
and mouse scalps were separated from fat tissue, washed twice with
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sterile PBS at 41C, and frozen in liquid nitrogen. Unfixed 7 mm
cryostat sections of human and rat skin were prepared as described
previously (Buniatian et al., 1996b). After fixation in methanol
(201C), the cells and tissue slices were washed with PBS at room
temperature. In monolabelling studies, the cells were exposed to
pAb anti-GFAP antiserum, or to mouse mAbs against GFAP, or
against SMAA, or against MHC II. Double-immunolabelling studies
were performed using mixtures of pAb anti-GFAP with mAbs against
either MT, or desmin, or vimentin, or SMAA, or MHC II. The mAb
MT used in this study specifically reacted with Cd/Zn-MT-I produced
by SMAA-positive astrocytes, HSCs, podocytes, and mast cells
(Buniatian et al., 2001, 2002). After 2 hour incubation at room
temperature, specimens were washed and exposed for 1 hour at
room temperature to a mixture of the secondary antibodies: FITC-
conjugated anti-rabbit IgG and Cy3-conjugated anti-mouse IgG. All
antibodies were diluted with PBS in concentrations indicated above.
After washing the cells with PBS containing Triton X-100 (Sigma,
Deisenhofen, Germany), the cells and tissues were mounted in Vecta-
shield mounting medium containing DAPI (Vector Laboratories,
Burlingame, CA) and examined with a fluorescence microscope
B 51 (Olympus Optical Co. Europe, Hamburg, Germany) with
UplanFI 20 /0.5 Ph1; UPlanFI 10 /0.30 Ph1; UPlanFI 40 /0.75
Ph2 objectives. Images were taken with the digital camera F-View II
(Soft Imaging System, Leinfelden-Echterdingen, Germany) at room
temperature and data were processed with AnalysisDOKUs
(Imaging System GmbH, Leinfelden-Echterdingen, Germany). The
rat and mouse skin was fixed in ice-cold methanol without preliminary
treatment.
CLS microscopy
CLS microscopy was performed on a Leica SL CLS microscope
equipped with an argon/krypton laser (Leica Lasertechnik, Heidelberg,
Germany). To improve the signal-to-noise ratio, eight scans of one
focal plane were averaged. The confocal image data were obtained
using a PLANAPO 63 , 1.32 NA oil immersion objective and CLS
microscope software (Leica Lasertechnik), and processed with Adobe
Photoshop 7.0 software (Adobe Systems Inc., Mountain View, CA).
Immunoblotting
Separation of the proteins from newborn rat skin and brain
homogenates and T6 cell line and newborn rat astroglial culture
homogenates was performed in SDS-PAGE according to Laemmli,
(1970) and the proteins were electroblotted onto a nitrocellulose
membrane (Burnette, 1981). Briefly, SDS-PAGE was conducted
using 10% (w/v) acrylamide gels. The proteins were electroblotted
onto a nitrocellulose membrane at a current of 0.3 A for 12 hours in
transfer buffer (25 mM Tris, 192 mM glycine, pH 9.0). The membrane
was blocked using 5% (w/v) milk powder in incubation buffer
(20 mM Tris-HCl, 150 mM NaCl, 0.02% (w/v) Tween-20, pH 7.4) at
room temperature for 1 hour. The filters were washed four times with
incubation buffer and incubated with mAb GFAP (dilution 1:1000;
Progen Biotechnik GmbH, Heidelberg, Germany) overnight. Subse-
quently, the membrane was incubated with horseradish-peroxidase-
conjugated anti-mouse IgG (secondary antibody) at a dilution of
1:1000 for 3–5 minutes. The membrane was washed four times with
incubation buffer and immunocomplexes were visualized using
luminol-based enhanced chemiluminescence Western blotting
reagent (ECLR, Amersham Biosciences, Freiburg, Germany).
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